Search Browse Earnings

Biofrontera Inc. — SlamSEC

Biofrontera Inc.

Nasdaq:BFRINasdaq:BFRIW

Pharmaceutical Preparations·WOBURN, MA

Overview All Filings Sum Fin Credit Insiders Governance

Overview All Filings Sum Fin Credit Insiders Governance

Summary Financials

CEO

Luebbert Hermann

CFO

Leffler Eugene Frederick

Revenue

$34.1M

+18.8% YoY

FY 2024

Adj. EBITDA

-$22.1M

-64.8% margin

FY 2024

Net Income

-$20.1M

-59.1% margin

FY 2024

EPS (Diluted)

-$13.02

FY 2024

Stock Price

$0.87

+2.8%

2026-03-12

52W Range

$0.54 – $1.19

P/E Ratio

-0.1x

Market Cap

$10.1M

Cash

$1.3M

FY 2024

Total Debt

$3.9M

FY 2024

Net Debt

$2.6M

FY 2024

Enterprise Value

$12.7M

Debt / EBITDA

-0.1x

FY 2024

EV / EBITDA

-0.6x

Employees

—